Voloridge Investment Management
MRNA icon

Voloridge Investment Management’s Moderna MRNA Stock Holding History

Voloridge Investment Management’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-485,719
Closed -$24.7M – 986
2026
Q1 		$24.7M Sell
485,719
-1,068,012
-69% -$49.8M 0.1% 292
2025
Q4 		$45.8M Buy
1,553,731
+584,329
+60% +$15.9M 0.16% 161
2025
Q3 		$25M Sell
969,402
-2,434,032
-72% -$67.9M 0.08% 291
2025
Q2 		$93.9M Buy
3,403,434
+142,888
+4% +$3.76M 0.35% 60
2025
Q1 		$92.4M Buy
3,260,546
+669,715
+26% +$23.8M 0.34% 75
2024
Q4 		$108M Buy
2,590,831
+1,996,003
+336% +$95.4M 0.38% 53
2024
Q3 		$39.8M Buy
+594,828
New +$54.6M 0.14% 211
2023
Q1 		– Sell
-175,961
Closed -$31.6M – 1522
2022
Q4 		$31.6M Sell
175,961
-75,942
-30% -$12.4M 0.18% 165
2022
Q3 		$29.8M Buy
251,903
+120,968
+92% +$18.4M 0.16% 181
2022
Q2 		$18.7M Buy
130,935
+105,619
+417% +$15.1M 0.1% 282
2022
Q1 		$4.36M Sell
25,316
-163,422
-87% -$27.5M 0.02% 683
2021
Q4 		$47.9M Buy
188,738
+119,068
+171% +$34.8M 0.26% 76
2021
Q3 		$26.8M Sell
69,670
-103,188
-60% -$38.1M 0.17% 134
2021
Q2 		$40.6M Sell
172,858
-19,268
-10% -$3.44M 0.28% 67
2021
Q1 		$25.2M Sell
192,126
-864,017
-82% -$125M 0.18% 143
2020
Q4 		$110M Buy
1,056,143
+675,609
+178% +$68.3M 0.93% 10
2020
Q3 		$26.9M Buy
+380,534
New +$26.5M 0.22% 108
2020
Q2 		– Sell
-59,304
Closed -$1.78M – 1415
2020
Q1 		$1.78M Sell
59,304
-101,943
-63% -$2.35M 0.05% 372
2019
Q4 		$3.15M Buy
+161,247
New +$2.86M 0.06% 386
2019
Q3 		– Sell
-29,111
Closed -$426K – 1165
2019
Q2 		$426K Buy
+29,111
New +$625K 0.01% 593

Other funds holding MRNA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.68B AUM 19.9% 1-Year Est. Return

Voloridge Investment Management's MRNA Position: Q2 2026 in Review

Voloridge Investment Management sold out of Moderna (MRNA) in Q2 2026, closing a stake of 485,719 shares — an estimated $24.7M sold.

Voloridge Investment Management first reported a position in MRNA in Q2 2019 and held it in 20 quarters. The position peaked at $110M in Q4 2020. 782 funds tracked by Wall St. Rank hold MRNA as of Q2 2026.

  • Voloridge Investment Management reported no remaining Moderna position as of Q2 2026 after selling out during the quarter.
  • Voloridge Investment Management sold 485,719 Moderna shares in Q2 2026, an estimated $24.7M.
  • Voloridge Investment Management first reported a position in Moderna in Q2 2019 and held it in 20 quarters.
  • Voloridge Investment Management's Moderna position peaked at $110M in Q4 2020.
  • 782 funds tracked by Wall St. Rank held Moderna as of Q2 2026.

Based on Voloridge Investment Management's 13F filing for Q2 2026, filed 14 Aug 2026.